2nd Quarter - Report

CHAMBER HILL STRATEGIES for GLAXOSMITHKLINE, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and monitoring of and broad payment reform issues included within H.R.2, Medicare Access and CHIP Reauthorization Act of 2015.

LobbyistCovered position, as disclosed
JENNIFER BELL Legislative Assistant, Rep. John Thune (R-SD)
MICHAELA SIMS Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2 (114th)

Health Issues HCR

Issues related to bio health security and vaccines

LobbyistCovered position, as disclosed
JENNIFER BELL Legislative Assistant, Rep. John Thune (R-SD)
MICHAELA SIMS Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

S.1137, The Patent Act; the Protecting American Talent and Entrepreneurship act of 2015.

LobbyistCovered position, as disclosed
JENNIFER BELL Legislative Assistant, Rep. John Thune (R-SD)
MICHAELA SIMS Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1137 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.